Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Intangibles (2011 - 2026)

Perspective Therapeutics' (CATX) quarterly Intangibles came in at $40.0 million in Q2 2026, down 20.0% year-over-year from $50.0 million in Q2 2025, and little changed quarter-over-quarter from $40.0 million in Q1 2026.

Analysis

Perspective Therapeutics (CATX) Intangibles (2011 - 2026) Analysis & Trends

Perspective Therapeutics has disclosed Intangibles across 8 years of filings, most recently posting $40.0 million for Q2 2026.

  • In Q2 2026, Intangibles fell 20.0% year-over-year to $40.0 million; the TTM figure through Jun 2026 stood at $40.0 million (down 20.0% YoY), while the FY2025 annual figure was $40.0 million, down 20.0% from the prior year.
  • Intangibles came in at $40.0 million for Q2 2026 at Perspective Therapeutics, roughly flat from $40.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.0 million in Q1 2023 to a low of $40.0 million in Q4 2025.
  • Average Intangibles over 4 years is $47.9 million, with a median of $50.0 million recorded in 2023.
  • Year-over-year, Intangibles changed 0.0% in 2024 and slipped 20.0% in 2025.
  • Over 4 years, Intangibles stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then retreated by 20.0% to $40.0 million in 2025, then changed by 0.0% to $40.0 million in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $40.0 million in Q2 2026, $40.0 million in Q1 2026, and $40.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 266.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Perspective Therapeutics 361.95 Mn 361.95 Mn - 40.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.00 Mn
Mar 31, 2026 40.00 Mn
Dec 31, 2025 40.00 Mn
Sep 30, 2025 50.00 Mn
Jun 30, 2025 50.00 Mn
Mar 31, 2025 50.00 Mn
Dec 31, 2024 50.00 Mn
Sep 30, 2024 50.00 Mn
Jun 30, 2024 50.00 Mn
Mar 31, 2024 50.00 Mn
Dec 31, 2023 50.00 Mn
Sep 30, 2023 50.00 Mn
Jun 30, 2023 50.00 Mn
Mar 31, 2023 50.00 Mn
Jun 30, 2015 198,490.00
Jun 30, 2014 223,756.00
Jun 30, 2012 203,256.00
Jun 30, 2011 203,194.00